Osugacestat

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C26H26F6N4O3
Molecular Weight	556.5001
Optical Activity	( - )
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of Osugacestat

Structure Search

SMILES

CN1C2=CC=CC=C2C(=N[C@H](NC(=O)[C@H](CCC(F)(F)F)[C@H](CCC(F)(F)F)C(N)=O)C1=O)C3=CC=CC=C3

InChI

InChIKey=AYOUDDAETNMCBW-GSHUGGBRSA-N

InChI=1S/C26H26F6N4O3/c1-36-19-10-6-5-9-18(19)20(15-7-3-2-4-8-15)34-22(24(36)39)35-23(38)17(12-14-26(30,31)32)16(21(33)37)11-13-25(27,28)29/h2-10,16-17,22H,11-14H2,1H3,(H2,33,37)(H,35,38)/t16-,17+,22+/m0/s1

HIDE SMILES / InChI

Molecular Formula	C26H26F6N4O3
Molecular Weight	556.5001
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	3 / 3
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 06:11:23 UTC 2023` Edited by `admin` on `Sat Dec 16 06:11:23 UTC 2023`
Record UNII	DRL23N424R
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Osugacestat

Official Name

English

AL101

Code

English

BMS 906024 [WHO-DD]

Common Name

English

OSUGACESTAT [USAN]

Common Name

English

Butanediamide, N1-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)-, (2R,3S)-

Systematic Name

English

osugacestat [INN]

Common Name

English

BM-0018

Code

English

BM0018

Code

English

AL-101

Code

English

BMS-906024

Code

English

(2R,3S)-N-((3S)-1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)-2,3-bis(3,3,3-trifluoropropyl)succinamide

Systematic Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

683819

Created by admin on Sat Dec 16 06:11:23 UTC 2023 , Edited by admin on Sat Dec 16 06:11:23 UTC 2023

Code System Code Type Description

INN

11648

Created by admin on Sat Dec 16 06:11:23 UTC 2023 , Edited by admin on Sat Dec 16 06:11:23 UTC 2023

PRIMARY

INN

USAN

JK-36

Created by admin on Sat Dec 16 06:11:23 UTC 2023 , Edited by admin on Sat Dec 16 06:11:23 UTC 2023

PRIMARY

EPA CompTox

DTXSID30161234

Created by admin on Sat Dec 16 06:11:23 UTC 2023 , Edited by admin on Sat Dec 16 06:11:23 UTC 2023

PRIMARY

DRUG BANK

DB12006

Created by admin on Sat Dec 16 06:11:23 UTC 2023 , Edited by admin on Sat Dec 16 06:11:23 UTC 2023

PRIMARY

WIKIPEDIA

BMS-906024

Created by admin on Sat Dec 16 06:11:23 UTC 2023 , Edited by admin on Sat Dec 16 06:11:23 UTC 2023

PRIMARY

NCI_THESAURUS

C116872

Created by admin on Sat Dec 16 06:11:23 UTC 2023 , Edited by admin on Sat Dec 16 06:11:23 UTC 2023

PRIMARY

SMS_ID

100000175215

Created by admin on Sat Dec 16 06:11:23 UTC 2023 , Edited by admin on Sat Dec 16 06:11:23 UTC 2023

PRIMARY

CAS

1401066-79-2

Created by admin on Sat Dec 16 06:11:23 UTC 2023 , Edited by admin on Sat Dec 16 06:11:23 UTC 2023

PRIMARY

FDA UNII

DRL23N424R

Created by admin on Sat Dec 16 06:11:23 UTC 2023 , Edited by admin on Sat Dec 16 06:11:23 UTC 2023

PRIMARY

PUBCHEM

66550890

Created by admin on Sat Dec 16 06:11:23 UTC 2023 , Edited by admin on Sat Dec 16 06:11:23 UTC 2023

PRIMARY

Related Record Type Details


					Q0AJ4B9B5N

NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 3 (HUMAN)

TARGET -> INHIBITOR

Amount:


					Q0AJ4B9B5N

NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 3 (HUMAN)

TARGET -> INHIBITOR

Qualification:

IC50

Amount:


					2GWO8DN9N6

NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 2

TARGET -> INHIBITOR

Qualification:

IC50

Amount:


					9372WZW6L3

.GAMMA.-SECRETASE

TARGET -> INHIBITOR

Amount:


					PE35I3T5TN

NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1

TARGET -> INHIBITOR

Qualification:

IC50

Amount:

Related Record Type Details


					DRL23N424R

ACTIVE MOIETY

Amount: